cancer clinical trials for Leukemia/MDS/MPD (ONC)

15 Leukemia/MDS/MPD (ONC) clinical trials found. View a list of all cancer clinical trial types.

• A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease

  Current Status: Open

  View links and contact information related to this clinical trial

• Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease. Applied Biomarkers in Late Effects (ABLE) 3.0 (CTTC 2201)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase I, single-arm, open label, dose escalation, multicenter study of off-the-shelf natural killer (NK) cells (SAR445419) in participants with relapsed or refractory acute myeloid leukemia (R/R) AML

  Current Status: Open

  View links and contact information related to this clinical trial

• Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial

• Resilience in Older Adults with Leukemia Receiving Initial Treatment: The ROAR-1 Study

  Current Status: Open

  View links and contact information related to this clinical trial

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

  Current Status: Open

  View links and contact information related to this clinical trial

• Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel

  Current Status: Not Open

  View links and contact information related to this clinical trial

• An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase II Study of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia

  Current Status: Open

  View links and contact information related to this clinical trial

• Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  Current Status: Open

  View links and contact information related to this clinical trial

• Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

  Current Status: Open

  View links and contact information related to this clinical trial

• Neurocognitive and Functional Outcomes of Older Adults with Myeloid Malignancies

  Current Status: Open

  View links and contact information related to this clinical trial

• Treatment practices and outcomes of adults with therapy-related acute myeloid leukemia (AML) and AML with myelodysplasia related changes

  Current Status: Open

  View links and contact information related to this clinical trial

• Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia and Non-Hodgkin's Lymphoma

  Current Status: Open

  View links and contact information related to this clinical trial